SCHEMBL2176484

SCHEMBL2176484

COC(C(=O)NC(=O)C1CCCN1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C19 P33261 1/20 0.55
TSHR P16473 2/20 0.51
CYP2C9 P11712 1/20 0.51
CCNA2 P20248 2/20 0.46
CDK2 P24941 2/20 0.46
CCNA1 P78396 2/20 0.46
SLC6A3 Q01959 4/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 1/20 0.46
DHFR P00374 1/20 0.46
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CTSC P53634 1/20 0.45
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980125 0.83 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL13570515 0.83 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL13570392 0.80 CYP3A4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL13570579 0.79 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL976838 0.75 RECQL (0.62) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL7313727 0.75 RECQL (0.62) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL7313737 0.75 RECQL (0.62) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL24057819 0.74 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL7305357 0.74 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19TSHR
SCHEMBL24056571 0.74 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519506-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-11-07 EP claimed
WO-2011082077-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-07 WO claimed